COVERA-HS Drug Patent Profile

✉ Email this page to a colleague

When do Covera-hs patents expire, and when can generic versions of Covera-hs launch?

Covera-hs is a drug marketed by Pfizer and is included in one NDA.

The generic ingredient in COVERA-HS is verapamil hydrochloride. There are seventeen drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the verapamil hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Covera-hs

A generic version of COVERA-HS was approved as verapamil hydrochloride by EXELA PHARMA on March 30^th, 1984.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for COVERA-HS?
What are the global sales for COVERA-HS?
What is Average Wholesale Price for COVERA-HS?

Summary for COVERA-HS

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	78
Clinical Trials:	4
DailyMed Link:	COVERA-HS at DailyMed

Drug patent expirations by year for COVERA-HS

Recent Clinical Trials for COVERA-HS

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Assiut University	Early Phase 1
Gillette Children's Specialty Healthcare	Phase 2
Dartmouth-Hitchcock Medical Center	Phase 2

See all COVERA-HS clinical trials

US Patents and Regulatory Information for COVERA-HS

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pfizer	COVERA-HS	verapamil hydrochloride	TABLET, EXTENDED RELEASE;ORAL	020552-001	Feb 26, 1996		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Pfizer	COVERA-HS	verapamil hydrochloride	TABLET, EXTENDED RELEASE;ORAL	020552-002	Feb 26, 1996		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for COVERA-HS

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Pfizer	COVERA-HS	verapamil hydrochloride	TABLET, EXTENDED RELEASE;ORAL	020552-001	Feb 26, 1996	⤷ Sign Up	⤷ Sign Up
Pfizer	COVERA-HS	verapamil hydrochloride	TABLET, EXTENDED RELEASE;ORAL	020552-001	Feb 26, 1996	⤷ Sign Up	⤷ Sign Up
Pfizer	COVERA-HS	verapamil hydrochloride	TABLET, EXTENDED RELEASE;ORAL	020552-001	Feb 26, 1996	⤷ Sign Up	⤷ Sign Up
Pfizer	COVERA-HS	verapamil hydrochloride	TABLET, EXTENDED RELEASE;ORAL	020552-001	Feb 26, 1996	⤷ Sign Up	⤷ Sign Up
Pfizer	COVERA-HS	verapamil hydrochloride	TABLET, EXTENDED RELEASE;ORAL	020552-002	Feb 26, 1996	⤷ Sign Up	⤷ Sign Up
Pfizer	COVERA-HS	verapamil hydrochloride	TABLET, EXTENDED RELEASE;ORAL	020552-002	Feb 26, 1996	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for COVERA-HS

See the table below for patents covering COVERA-HS around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
France	2622798	FORME D'APPORT DOSE ET DISPOSITIF OSMOTIQUE D'ADMINISTRATION D'UN MEDICAMENT POUR LE TRAITEMENT DE MALADIES CARDIO-VASCULAIRES	⤷ Sign Up
South Africa	8807362		⤷ Sign Up
Finland	110919		⤷ Sign Up
Norway	304580		⤷ Sign Up
Austria	394944		⤷ Sign Up
South Africa	9204772		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for COVERA-HS

Recent Clinical Trials for COVERA-HS

Make Better Decisions: Try a trial or see plans & pricing